CAS: 90856-77-2; 4,6-Dimethylpyrimidin-5-Amine

该化合物是一种环环生物化合物,其4和6个位置上以甲基组取代了火水晶核心,5个位置上以甲基组取代了地雷组,这一结构在合成应用中具有多功能性,特别是作为制药和农用化学的一个构件,其富电芳香系统和反应性地雷组有助于进一步实现功能化,使其对建设复杂的分子框架具有价值.该化合物在标准条件下表现出稳定性,确保了可靠的处理和储存.其明确界定的再活性特征可以进行精确的修改,支持其在医药化学和材料科学研究中的使用.高纯度等级可以满足严格的工业和学术要求.

结构式图片

相似化合物

3438-61-7 35733-53-0 1368911-16-3

上下游产品

4,6-dimethyl-2(1H)-pyrimidinone acetylacetone 4,6-dimethyl-5-nitro-2-hydroxypyrimidine 2-chloro-4,6-dimethyl-5-nitropyrimidine

合成工艺路线路线简述

    📜4,6-二甲基-5-硝基嘧啶-2-醇置于palladium 10% On Activated Carbon,氢气,三氯氧磷体系中,用 乙醇 作为反应溶剂,化学反应 10.0H,反应生成 5-氨基-4,6-二甲基嘧啶
    参考文献: Pyrazolopyridines Useful In The Treatment Of Disorders Of The Central Nervous System[fr] Pyrazolopyridines Utiles Dans Le Traitement De Troubles Du Système Nerveux Central
    标题: Pyrazolopyridines Useful In The Treatment Of Disorders Of The Central Nervous System[fr] Pyrazolopyridines Utiles Dans Le Traitement De Troubles Du Système Nerveux Central
    摘要:本发明涉及在治疗中有用的化合物,包括含有这些化合物的组合物,以及治疗疾病的方法,包括给予这些化合物的管理.所指的化合物是尼古丁乙酰胆碱α7受体的正向变构调节剂(pams).

    专利信息


    专利号:US-4800207-A
    优先权日:1987-11-02
    标题:Hexahydropyrrolizine compounds useful as analgesics
    发明人:CARMOSIN RICHARD J; CARSON JOHN R
    权利人:MCNEILAB INC
    摘要:Hexahydropyrrolizines of the formula (I): (I) wherein A is a 3-7 carbon or hetero-containing ring, R1 is a substituent, and x is 0-3. Also, pharmaceutical compositions for treating pain and methods for synthesis and use as well as novel intermediates in the synthesis.

    专利号:US-4716172-A
    优先权日:1986-04-10
    标 题 :4-substituted octahydroquinolizine analgesic compounds and octahydroquinolizinium intermediates
    发明人:CARMOSIN RICHARD J; CARSON JOHN R
    权利人:MCNEILAB INC
    摘要:Octahydroquinolizine and corresponding octahydroquinolizinium compounds of formulae (I) and (Va): where A is a 3 to 7 membered carbocyclic ring, R1 is a substituent, n is 0-2, x is 0-3, and Y is an anion. Also, pharmaceutical compositions for treating pain containing (I) and methods for synthesis and use as well as novel intermediates in the synthesis.

    专利号:US-4689329-A
    优先权日:1986-02-04
    标 题:5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
    发明人:CARMOSIN RICHARD J; CARSON JOHN R
    权利人:MCNEILAB INC
    摘要:Octahydroindolizidines and corresponding ketones of the formulae (I) and (II): (I) (II) where A is a 3-7 carbon or hetero-containing ring, R1 is a substituent, n is 0-6 and x is 0-3. Also, pharmaceutical compositions for treating pain containing (I) or (II) and methods for synthesis and use as well as novel intermediates in the synthesis.

    专利号:US-4582836-A
    优先权日:1985-01-09
    标 题:Octahydroindolizine compounds useful as analgesics
    发明人:CARMOSIN RICHARD J; CARSON JOHN R
    权利人:MCNEILAB INC
    摘要:Octahydroindolizidines of the formula (I): ##STR1## where A is a 3-7 carbon or hetero-containing ring, R 1 is a substituent and x is 0-3. Also, pharmaceutical composition for treating pain and methods for synthesis and use as well as novel intermediates in the synthesis.

    专利号:US-2004138238-A1
    优先权日:2002-08-08
    标题 :Substituted aminopyrimidine compounds as neurokinin antagonists
    发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; KESAVAN VENKITASAMY; SHARADENDU ANURAG; MOHANTY PRADYUMNA; CHEN DONGLI; CHERUKU SRINIVASA RAO; HEIFETZ ALEXANDER; KALID ORI; MARANTZ YAEL; NUDELMAN RAPHAEL; SBACHAM SHARON; BAR-HAIM SHAY
    摘要:The invention discloses tachykinin receptor antagonists. The tachykinin family of receptors comprising the neurokinins substance P (SP), neurokinin A, and neurokinin B and related neuropeptides that are widely distributed in the peripheral and central nervous system. The invention discloses novel aminopyrimidine derivatives, synthesis and uses thereof for the treatment of diseases mediated directly or indirectly by the tachykinin receptors. These diseases include central nervous system disorders such as anxiety, pain, depression, emesis, in particular cancer chemotherapy induced emesis, respiratory and inflammatory bowel disease and other gastric disorders, asthma, schizophrenia, ophthalmic diseases such as glaucoma, ocular hypotension, neural injury, stroke, cardiac disorders, psoriasis, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.

    专利号:US-5728695-A
    优先权日:1994-12-23
    标题 :Spiroketal derivatives, compositions containing them and their use as therapeutic agents
    发明人:HARRISON TIMOTHY; OWEN SIMON NEIL; SEWARD EILEEN MARY; SWAIN CHRISTOPHER JOHN
    权利人:MERCK SHARP & DOHME
    摘要:The present invention relates to spiroketal derivatives of formula (I) and pharmaceutically acceptable salts thereof wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 9a , R 9b , m and n are as defined in the specification, and to processes for their preparation, to intermediates used in their synthesis, to pharmaceutical compositions containing them, and to their use in therapy. The compounds are of particular use in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia. ##STR1##

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/bf00742848
    摘要:Dubovenko ZD, Mamaev VP. Pyrimidines. 72. Synthesis and some properties of 5-amino-2-r-4,6-diphenylpyrimidines and the products of their transformations. Chemistry of Heterocyclic Compounds. 1980 Sep;16(9):970–3. doi: 10.1007/bf00742848.
    参考文献:10.1007/bf00742847
    摘要:Kost AN, Terenin VI, Yudin LG, Sagitullin RS. Recyclization of 3-alkyl- and 1,3-dialkylisoquinolinium salts to naphthylamines. Chemistry of Heterocyclic Compounds. 1980 Sep;16(9):965–70. doi: 10.1007/bf00742847.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知